Have a personal or library account? Click to login
Dyskinesia-Hyperpyrexia Syndrome in Parkinson’s Disease May Benefit from GPi Deep Brain Stimulation: A Case Report Cover

Dyskinesia-Hyperpyrexia Syndrome in Parkinson’s Disease May Benefit from GPi Deep Brain Stimulation: A Case Report

Open Access
|May 2025

References

  1. 1Jankovic J. Motor fluctuations and dyskinesias in Parkinson’s disease: clinical manifestations. Mov Disord. 2005;20 Suppl 11:S116. DOI: 10.1002/mds.20458
  2. 2Simonet C, Tolosa E, Camara A, Valldeoriola F. Emergencies and critical issues in Parkinson’s disease. Pract Neurol. 2020;20:1525.
  3. 3Gil-Navarro S, Grandas F. Dyskinesia-hyperpyrexia syndrome: another Parkinson’s disease emergency. Mov Disord. 2010;25:26912. DOI: 10.1002/mds.23255
  4. 4Wang JY, Huang JF, Zhu SG, Huang SS, Liu RP, Hu BL, et al. Parkinsonism-Hyperpyrexia Syndrome and Dyskinesia-Hyperpyrexia Syndrome in Parkinson’s Disease: Two Cases and Literature Review. J Parkinsons Dis. 2022;12:172735. DOI: 10.3233/JPD-223362
  5. 5Herreros-Rodriguez J, Sanchez-Ferro A. Summertime Dyskinesia-Hyperpyrexia Syndrome: The “Dual Heat” Hypothesis. Clin Neuropharmacol. 2016;39:2101. DOI: 10.1097/WNF.0000000000000155
  6. 6Baek MS, Lee HW, Lyoo CH. A Patient with Recurrent Dyskinesia and Hyperpyrexia Syndrome. J Mov Disord. 2017;10:1547. DOI: 10.14802/jmd.17022
  7. 7Fan SY, Wang KL, Hu W, Eisinger RS, Han A, Han CL, et al. Pallidal versus subthalamic nucleus deep brain stimulation for levodopa-induced dyskinesia. Ann Clin Transl Neurol. 2020;7:5968. DOI: 10.1002/acn3.50961
  8. 8Sarchioto M, Ricchi V, Melis M, Deriu M, Arca R, Melis M, et al. Dyskinesia-Hyperpyrexia Syndrome in Parkinson’s Disease: A Heat Shock-Related Emergency? Mov Disord Clin Pract. 2018;5:5347. DOI: 10.1002/mdc3.12663
  9. 9Kao TY, Chio CC, Lin MT. Hypothalamic dopamine release and local cerebral blood flow during onset of heatstroke in rats. Stroke. 1994;25:24836; discussion 6–7. DOI: 10.1161/01.STR.25.12.2483
  10. 10Cenci MA, Konradi C. Maladaptive striatal plasticity in L-DOPA-induced dyskinesia. Prog Brain Res. 2010;183:20933. DOI: 10.1016/S0079-6123(10)83011-0
  11. 11Jenner P. Molecular mechanisms of L-DOPA-induced dyskinesia. Nat Rev Neurosci. 2008;9:66577. DOI: 10.1038/nrn2471
  12. 12Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson’s disease. N Engl J Med. 2010;362:207791. DOI: 10.1056/NEJMoa0907083
  13. 13Lozano AM, Lipsman N, Bergman H, Brown P, Chabardes S, Chang JW, et al. Deep brain stimulation: current challenges and future directions. Nat Rev Neurol. 2019;15:14860. DOI: 10.1038/s41582-018-0128-2
  14. 14Limousin P, Foltynie T. Long-term outcomes of deep brain stimulation in Parkinson disease. Nat Rev Neurol. 2019;15:23442. DOI: 10.1038/s41582-019-0145-9
DOI: https://doi.org/10.5334/tohm.912 | Journal eISSN: 2160-8288
Language: English
Submitted on: Apr 30, 2024
Accepted on: Apr 26, 2025
Published on: May 7, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2025 Shi-Shi Huang, Lu-Lu Ma, Han-Song Sheng, Rong-Pei Liu, Shi-Guo Zhu, Shan-Shan Xu, Mei-Ling Sheng, Zhu-Ling Chen, Nu Zhang, Xiong Zhang, Jian-Yong Wang, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.